Moderna down 13% premarket after FDA official resigns - Breaking The News

Moderna down 13% premarket after FDA official resigns

31 March

1 min read

EPA-EFE/CJ GUNTHER

Shares of the biotechnology company Moderna Inc. dropped over 13% during Monday's premarket hours following the news that the Food and Drug Administration's (FDA) top vaccine official, Peter Marks, had resigned.

According to a Department of Health and Human Services representative on Friday, Marks, who led the FDA's vaccine division, was presented with an ultimatum to either resign or be fired. A source close to the situation informed NBC News that the Trump administration had forced his departure.

The firm's stock plunged 13.56%, going for $26.76 apiece at 7:36 am ET.

moderna

Related Stocks

Moderna

Moderna wins against Biontech, Pfizer in patent dispute

5 March

A Dusseldorf court ruled in favor of Moderna in a patent dispute against Biontech and Pfizer on Tuesday, ordering them to disclose profits and compensate for unauthorized use of patented mRNA technology.Moderna claimed the companies copied innovations it had developed between 2010 and 2016 for their COVID-19 vaccine. Biontech and Pfizer argued they had permission to use the patent until May 5, 2023, based on a statement Moderna issued in 2020....

Moderna's Q4 revenue falls 65% to $966 million

14 February

Moderna Inc. revealed on Friday that its total revenue landed at $966 million in the fourth quarter of its fiscal 2024, falling by 65% from the same period a year ago. The figure came above market estimates.In the fourth quarter, the biotechnology giant reported a $1.1 billion net loss, compared to the $217 million net income seen last year. Its diluted loss per share came in at $2.91, from $0.57 earnings per share compared to the corresponding quarter in...

Earnings preview: Asian companies in limelight

10 February

Although some of the most anticipated global players have already released their fresh financial results, this week investors' attention will turn to some of the leading Asian companies. Namely, SoftBank is expected to unveil its report on Wednesday, followed by Sony, Nissan, and Honda on Thursday.In addition to the Asian business giants, the European banking sector will be closely watched, as UniCredit, Commerzbank, Barclays, and NatWest will post earnings...

Vaccine stocks fall after RFK Jr.'s HHS nomination advances

4 February

Shares of vaccine makers, including Moderna, Pfizer, and BioNTech, dipped Tuesday after the Senate Finance Committee advanced Robert F. Kennedy Jr.'s nomination for Health and Human Services secretary.The 14-13 party-line vote moved the controversial pick to the Senate floor. Kennedy, known for his skepticism of vaccines, has drawn sharp criticism for his previous comments on vaccine safety.At 10:41 am ET, Moderna's stock fell 5.11% to $34.68,...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.